Archives: News
Drug Hunter Interview
Drug Hunter Flash Talk with Prof. Hande Ozdinler, Ph.D. and Prof. Richard B. Silverman, Ph.D.
A Long Swim
A Long Swim co-founder and executive director Doug McConnell sits down with Dr. Hande Ozdinler, A Long Swim Director of Science and Associate Professor of Neurology at Northwestern University, and Dr. Richard Silverman, Professor of Chemistry & Molecular Biosciences at Northwestern University, to discuss their most recent discovery of NU-9, the first compound that improves...
Akava receives Orphan Drug Designation status for AKV9
Akava Therapeutics, Inc. announces that on July 6, 2022, orphan drug designation (ODD) status was received for AKV9 for the treatment of amyotrophic lateral sclerosis (ALS) from the U.S. Food and Drug Administration (FDA), pursuant to section 526 of the Federal, Drug and Cosmetic Act (12 U.S.C.360bb). Obtaining orphan drug designation represents a significant company...
This time around, Lyrica’s inventor is developing his Northwestern discoveries at his own biotech
Richard Silverman was left in the dark for the last five years of clinical development of the drug he discovered. The Northwestern University professor found out about the first approval…